HR 3532, the Striking and Locked Out Workers Healthcare Protection Act, prohibits employers from terminating or altering an employee’s employer-sponsored health coverage during a lawful strike or a lockout (when an employer withholds work to influence bargaining). It directly affects workers participating in strikes or facing lockouts, ensuring continued healthcare access during these labor disputes. The bill adds penalties: $75,000 per violation for lockout-related coverage termination (up to $150,000 for repeat offenses), and $50,000 per violation for strike-related termination (up to $100,000 for repeat offenses), with penalties applied alongside other remedies. These provisions amend the National Labor Relations Act to protect workers’ healthcare rights during collective bargaining actions.
SRES 236 is a non-binding Senate resolution condemning Russia’s abduction and forced transfer of Ukrainian children, citing over 19,500 confirmed cases as of April 2025. It urges that all Ukrainian children abducted by Russia be returned before any peace agreement is finalized, emphasizing this as a prerequisite for a just resolution to the war. The resolution references Russia’s changed adoption laws, violations of international treaties, and documented human rights abuses against children in occupied territories. It does not create new law but formally expresses the Senate’s position on this issue.
HRES 431 is a symbolic resolution recognizing the Arctic Council’s role as a key forum for international cooperation on Arctic issues. It reaffirms the U.S. commitment to active participation in the Council, highlights the importance of Indigenous involvement, and urges sustained diplomatic engagement - including support for the U.S. Arctic Ambassador role - amid geopolitical shifts like Russia’s suspension from Council activities. The resolution does not create new laws or funding but expresses support for existing U.S. leadership in Arctic diplomacy.
The Supreme Court Ethics, Recusal, and Transparency Act of 2025 would establish a formal code of conduct for Supreme Court justices and require them to disclose gifts and financial interests. It creates procedures for filing complaints about justices' conduct, including a judicial investigation panel to review allegations of misconduct. The bill expands circumstances requiring justices to recuse themselves from cases, such as when they or their family received gifts from parties involved in a case. These provisions aim to increase transparency and accountability in the Supreme Court's operations, with new disclosure requirements for parties and amici curiae in court cases.
This bill creates a process for the Secretary of Health and Human Services to determine if brand name drug prices exceed those in five reference countries (Canada, UK, Germany, France, and Japan). If a drug is deemed excessively priced, the government will terminate the manufacturer's exclusivity rights and allow any company to produce a generic version under an open, non-exclusive license with a reasonable royalty. Drug manufacturers must submit detailed annual reports on pricing, costs, and revenues, with penalties for noncompliance. The Secretary will maintain a public database of excessive price determinations and report annually to Congress. This directly impacts brand name drug manufacturers, generic producers, and patients who purchase prescription drugs.
This bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2028 and report detailed transparency data starting in 2027. Plans must publicly disclose approval/denial rates, average processing times (including for appeals), technology use, and other metrics for covered medical services. It mandates 24-hour response standards for expedited requests and routinely approved services, with data collection to analyze access patterns and potential disparities in rural/low-income communities. These changes directly affect Medicare Advantage plans, providers, and seniors enrolled in these plans by standardizing and increasing visibility into prior authorization processes.
This bill expands benefits for public safety officers (like police and firefighters) who develop certain cancers linked to their work. It creates a presumption that specific cancers - such as lung, bladder, or mesothelioma - were caused by job-related exposure to carcinogens, if the officer served at least 5 years, was diagnosed within 15 years of leaving active duty, and the cancer caused death or permanent disability. The list of covered cancers will be updated every 3 years based on medical evidence from agencies like the National Institute for Occupational Safety and Health. Claims must be filed within 3 years of the bill’s enactment, applying to cases involving deaths or disabilities occurring after January 1, 2020.
This bill would allocate $200 million annually from 2026 through 2029 to expand access to diapers and incontinence supplies for low-income families. It specifically targets infants, toddlers, medically complex children, and low-income adults with disabilities who require diapers or incontinence products. The funding would be distributed through state social services programs to support free distribution of diapers, diapering supplies, and adult incontinence materials, while requiring states to track how funds are used through detailed reporting. The bill also makes medically necessary diapers and diapering supplies eligible for reimbursement through health savings accounts and flexible spending arrangements. This legislation aims to address what is termed "diaper need" by directly providing essential supplies to vulnerable populations.
Clinical Trial Modernization Act This bill authorizes a grant program and provides certain exemptions to support the participation of individuals in clinical trials. Specifically, the bill authorizes a grant program to support outreach, education, and recruitment efforts for clinical trials that may benefit certain underrepresented populations or communities in need, such as rural or tribal areas. The bill also exempts from anti-kickback laws for federal health care programs (1) remuneration that is offered to cover participants' expenses to participate in clinical trials, (2) the provision of free digital health technologies to support participation of underrepresented populations in clinical trials, and (3) payment for participants' cost-sharing obligations in relation to clinical trials. Finally, the bill exempts up to $2,000 in remuneration that is received for participating in a clinical trial from income tax.
HR 3506 reauthorizes annual funding for the Healthy Food Financing Initiative through fiscal year 2030, setting specific mandatory funding levels starting at $25 million for 2026 and increasing to $50 million annually after 2029. The bill directs the Commodity Credit Corporation to allocate these funds to support projects expanding access to healthy food in underserved communities. It directly affects low-income neighborhoods lacking grocery stores and local food businesses seeking financing for development or expansion. The legislation provides no new policy mechanisms beyond establishing these fixed annual funding amounts.
This bill establishes a code of conduct for Supreme Court justices, requiring them to disclose gifts, income, and potential conflicts of interest. It creates a formal process for handling complaints about justices, including a judicial investigation panel to review allegations. The bill adds specific circumstances requiring recusal, such as when a justice or family member has financial ties to a party in a case. Additionally, it mandates that parties and amicus briefs disclose any gifts given to justices and lobbying activities related to their nomination. These provisions aim to increase transparency and accountability in the Supreme Court's operations.
HR 3505, the Barriers to Suicide Act of 2025, creates a federal grant program administered by the Department of Transportation to fund the installation of proven safety barriers and nets on specific high-risk structures. The program provides competitive grants (up to 80% federal funding) to states, local governments, or other eligible entities for projects installing suicide deterrents on bridges, buildings, parking garages, highway-rail crossings, or rail stations. It prioritizes areas with high suicide rates and mandates a study by the Comptroller General to evaluate effective deterrents for non-bridge structures and their costs, with a report due within one year of enactment. The bill authorizes $10 million annually from 2026-2030 for this initiative.
